Because APC and other Wnt signaling members are critical to the development, progression, and recurrence of CRC, components of the Wnt/β-catenin signaling pathway may correspond to a promising source therapeutic targets for CRC treatment. The gene discussed is APC; the disease is colorectal carcinoma.